Kanteron Systems USA, Inc. today announced that John Memarian, President of International Businesses at Merge (recently acquired by IBM), will be joining Kanteron in a newly created position, as President and Chief Commercial Officer, joining the executive team and reporting directly to Founder and CEO Jorge Cortell.
Memarian will be responsible for executing the commercial strategy and business development of Kanteron, overseeing activities relating to marketing, sales, product development and customer service, to drive business growth and market share. Kanteron helps healthcare providers and EHR vendors manage imaging and genomic data effectively for precision medicine applications at the point of care, pioneering the integration of healthcare big data silos (medical imaging, pathology, genomics, pharmacogenomics and biosensors).
“I am thrilled that John will be joining our team,” said Cortell. “he shares our values and our focus on innovation, and he places the same strong emphasis as we do on customer satisfaction. He has shown himself to be an extraordinary leader throughout his career and has a proven track record.”
“I am profoundly honored to join Kanteron in this newly created position, and very much look forward to working with such an amazing team of innovators,” said Memarian. “I am completely convinced of the impact Kanteron products and services can have on the healthcare industry around personalized medicine and look forward to contributing to the company’s continued success and leadership in changing the healthcare world.”
Memarian will join Kanteron effective March 1st from Merge, where he currently serves as president of the International and OEM Businesses and has led the company through a period of outstanding global growth and the acquisition by IBM. Prior to Merge, he served a number of leadership roles and key involvements in business development initiatives in the healthcare industry’s leading organizations such as GE, McKesson, Leidos Consulting (Formerly maxIT Healthcare).
Kanteron develops TMIS, the world’s leading integrated platform for medical imaging and clinical genomics. Kanteron leads the healthcare big data revolution with its pragmatic approach to data integration, and is defining the future of personalized medicine.